Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by SHINICHI OHASHI
Radioimmunoassay for Glucagon-Like Peptide-1 in Human Plasma Using N-Terminal and C-Terminal Directed Antibodies: A Physiologic Insulinotropic Role Oe GLP-1( 7-36 Amide)
Biomedical Research
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
Effects of Subcutaneous Glucagon-Like Peptide 1 (GLP-1 [7-36 Amide]) in Patients With NIDDM
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
The Isolated N-Terminal Domain of the Glucagon-Like Peptide-1 (GLP-1) Receptor Binds Exendin Peptides With Much Higher Affinity Than GLP-1
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Glucagon-Like Peptide-1 Cleavage Product GLP-1(9-36) Amide Rescues Synaptic Plasticity and Memory Deficits in Alzheimer's Disease Model Mice
Journal of Neuroscience
Neuroscience
Effects of Glucagon-Like Peptide-1(7-36)amide on Motility and Sensation of the Proximal Stomach in Humans
Gut
Gastroenterology
Glucagon-Like Peptide-1 Receptor (GLP1R; GLP-1R)
Science-Business eXchange
Cardiovascular Effects of Glucagon-Like Peptide 1 (GLP-1) Receptor Agonists
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Pharmacokinetic, Insulinotropic, and Glucagonostatic Properties of GLP-1 [7?36 Amide] After Subcutaneous Injection in Healthy Volunteers. Dose-Response-Relationships
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pharmacokinetic, Insulinotropic, and Glucagonostatic Properties of GLP-1 [7?36 Amide] After Subcutaneous Injection in Healthy Volunteers. Dose-Response-Relationships
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Effect of Glucagon-Like Peptide 1(7-36) Amide on Glucose Effectiveness and Insulin Action in People With Type 2 Diabetes
Diabetes
Internal Medicine
Endocrinology
Metabolism
Diabetes
